annual Report 2009 - STRATEC Biomedical AG
annual Report 2009 - STRATEC Biomedical AG
annual Report 2009 - STRATEC Biomedical AG
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>Report</strong> of the board of Management<br />
<strong>Report</strong> of the supervisory board<br />
THE share<br />
Corporate Governance<br />
Group Management report<br />
Consolidated financial statements<br />
Consolidated Cash Flow Statement<br />
for the period from January 1 to December 31, <strong>2009</strong><br />
of <strong>STRATEC</strong> <strong>Biomedical</strong> Systems <strong>AG</strong><br />
Service<br />
in v thousand Note <strong>2009</strong> 2008<br />
I. Operations<br />
Consolidated net income 11,674 6,131<br />
Depreciation and amortization 2,573 2,285<br />
Current income tax expenses 3,754 3,555<br />
Income taxes paid less income taxes received -4,388 -4,809<br />
Financial income -120 -644<br />
Financial expenses 214 224<br />
Interest paid -215 -274<br />
Interest received 132 602<br />
Other non-cash expenses (12) 361 2,578<br />
Other non-cash income (12) -1,129 -999<br />
Change in net pension provisions (14) 96 0<br />
Cash flow 12,952 8,649<br />
Change in deferred taxes through profit or loss -329 -298<br />
Profit on disposals of non-current assets -202 -24<br />
Increase in inventories, trade receivables and other assets -7,520 -7,210<br />
Increase in trade payables and other liabilities 5,977 3,117<br />
Inflow of funds from operating activities 10,878 4,234<br />
II. Investments<br />
Incoming payments from disposals of non-current assets<br />
Property, plant and equipment 30 49<br />
Financial assets 797 0<br />
Outgoing payments for investments in consolidated non-current assets<br />
Intangible assets -328 -381<br />
Property, plant and equipment -1,895 -976<br />
Prepayments made / assets under construction -1,121 0<br />
Financial assets -209 -78<br />
Outgoing payments for acquisitions of consolidated companies,<br />
less cash and cash equivalents taken over -1,738 0<br />
Outflow of funds for investment activities -4,464 -1,386<br />
III. Financing<br />
Incoming payments from taking up of financial liabilities 0 1,000<br />
Outgoing payments for repayment of financial liabilities -712 -253<br />
Incoming payments from issues of shares for employee stock option programs 242 38<br />
Outgoing payments for acquisition of treasury stock 0 -2,001<br />
Dividend payments -3,977 -2,510<br />
Outflow of funds for financing activities -4,447 -3,726<br />
IV. Cash-effective change in cash and cash equivalents (Balance of I – III) 1,967 -878<br />
Cash and cash equivalents at start of period 19,208 19,884<br />
Change in cash and cash equivalents due to changes in exchange rates 12 202<br />
Cash and cash equivalents at end of period (12) 21,187 19,208<br />
stratec Annual <strong>Report</strong> <strong>2009</strong><br />
49
Change language